Abstract
Myocardial Blood Flow (MBF) is a key indicator of myocardial perfusion, typically assessed through additional clinical tests like dynamic CT perfusion under stress. This study introduces a digital twin designed to enhance coronary artery disease diagnosis by predicting MBF using data from routine CT images and clinical measurements. The digital twin employs AI methods to reconstruct coronary and myocardial geometries and integrates a computational model, featuring 3D coronary arteries and a three-compartment myocardial model, blindly calibrated with data from six representative patients. Validation on 28 additional patients showed MBF predictions consistent with experimental and clinical measurements. Confusion matrix analysis assessed the twin’s ability to classify at-risk patients (averaged MBF < 230 ml/min/100g) versus non-at-risk patients, yielding a recall of 0.77, with precision and accuracy at 0.72. This work represents the first attempt to predict and validate MBF on such a large cohort, paving the way for future clinical applications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the European Union- Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS- Project: PNRR-POC-2022-12376500, CONCERTO
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was carried out using the data collected by Centro Cardiologico Monzino for the PERFECTION study (registered with number R250/15-CCM 262). We report the statement of approval for PERFECTION study: "The institutional ethical committee study approved the protocol, and all patients meeting the selection criteria were asked to sign an informed consent. A structured interview was performed to collect a clinical history and cardiac risk factors."
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
